Kynam Capital Management, LP Caribou Biosciences, Inc. Transaction History
Kynam Capital Management, LP
- $1.28 Billion
- Q2 2024
A detailed history of Kynam Capital Management, LP transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Kynam Capital Management, LP holds 1,646,702 shares of CRBU stock, worth $3.64 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
1,646,702
Previous 1,068,527
54.11%
Holding current value
$3.64 Million
Previous $5.49 Million
50.84%
% of portfolio
0.21%
Previous 0.58%
Shares
2 transactions
Others Institutions Holding CRBU
# of Institutions
141Shares Held
53.3MCall Options Held
32.5KPut Options Held
89.8K-
Black Rock Inc. New York, NY6.95MShares$15.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$10 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.16MShares$9.2 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.08MShares$9.02 Million0.34% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.62MShares$5.8 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $134M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...